Alterity Net Income from 2010 to 2026
| ATHE Stock | USD 3.30 0.07 2.08% |
Net Loss | First Reported 1997-12-31 | Previous Quarter -7.2 M | Current Value -5 M | Quarterly Volatility 2.6 M |
Check Alterity Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Alterity Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 2.9 K, Other Operating Expenses of 24.2 M or Total Operating Expenses of 24 M, as well as many indicators such as Price To Sales Ratio of 10.06, Dividend Yield of 0.0 or PTB Ratio of 1.43. Alterity financial statements analysis is a perfect complement when working with Alterity Therapeutics Valuation or Volatility modules.
Alterity | Net Income | Build AI portfolio with Alterity Stock |
Analyzing Alterity Therapeutics's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing Alterity Therapeutics's current valuation and future prospects.
Latest Alterity Therapeutics' Net Income Growth Pattern
Below is the plot of the Net Income of Alterity Therapeutics over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Alterity Therapeutics financial statement analysis. It represents the amount of money remaining after all of Alterity Therapeutics operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Alterity Therapeutics' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Alterity Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (12.15 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Alterity Net Income Regression Statistics
| Arithmetic Mean | (10,202,795) | |
| Coefficient Of Variation | (43.46) | |
| Mean Deviation | 3,425,040 | |
| Median | (10,933,045) | |
| Standard Deviation | 4,434,341 | |
| Sample Variance | 19.7T | |
| Range | 19.1M | |
| R-Value | (0.70) | |
| Mean Square Error | 10.7T | |
| R-Squared | 0.49 | |
| Significance | 0 | |
| Slope | (615,658) | |
| Total Sum of Squares | 314.6T |
Alterity Net Income History
Other Fundumenentals of Alterity Therapeutics
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Alterity Therapeutics Net Income component correlations
About Alterity Therapeutics Financial Statements
Alterity Therapeutics stakeholders use historical fundamental indicators, such as Alterity Therapeutics' Net Income, to determine how well the company is positioned to perform in the future. Although Alterity Therapeutics investors may analyze each financial statement separately, they are all interrelated. For example, changes in Alterity Therapeutics' assets and liabilities are reflected in the revenues and expenses on Alterity Therapeutics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Alterity Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Loss | -10.9 M | -11.5 M | |
| Net Loss | -10.9 M | -11.5 M | |
| Net Loss | -12.4 M | -13 M | |
| Net Income Per E B T | 0.91 | 0.80 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Alterity Therapeutics is a strong investment it is important to analyze Alterity Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Alterity Therapeutics' future performance. For an informed investment choice regarding Alterity Stock, refer to the following important reports:Check out the analysis of Alterity Therapeutics Correlation against competitors. For information on how to trade Alterity Stock refer to our How to Trade Alterity Stock guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Will Biotechnology sector continue expanding? Could Alterity diversify its offerings? Factors like these will boost the valuation of Alterity Therapeutics. If investors know Alterity will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Alterity Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.59) | Revenue Per Share | Quarterly Revenue Growth 0.809 | Return On Assets | Return On Equity |
The market value of Alterity Therapeutics is measured differently than its book value, which is the value of Alterity that is recorded on the company's balance sheet. Investors also form their own opinion of Alterity Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Alterity Therapeutics' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Alterity Therapeutics' market value can be influenced by many factors that don't directly affect Alterity Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Alterity Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Alterity Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Alterity Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.